FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier

GLIA

Volumn 27, Issue 1, 1999, Pages 62-74

  Bechmann, Ingo ^a,c   Mor, Gil ^a   Nilsen, Jon ^a,b   Eliza, Mariel ^a   Nitsch, Robert ^c   Naftolin, Frederick ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; Blood brain barrier; FasL; Tolerance suppression

Indexed keywords

APOPTOSIS; BRAIN; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOLOGICAL BRAIN BARRIER; LYMPHOCYTE ACTIVATION; NERVE CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, SURFACE; APOPTOSIS; ASTROCYTES; BRAIN; ENTORHINAL CORTEX; FAS LIGAND PROTEIN; FEMALE; HIPPOCAMPUS; HUMANS; IN SITU NICK-END LABELING; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; MICROGLIA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEMPORAL LOBE;

EID: 0033168749     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO;2-S     Document Type: Article

References (42)

1. Bauer J, Bradl M, Hickey FW, Forss-Petter S, Breitschopf H, Linington C, Wekerle H, Lassmann H. 1998. T-cell apoptosis in inflamatory brain lesions. Destruction of T cells does not depend on antigen recognition. Am J Pathol 153:715-724.
2. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke R. 1995. A role for CD95 ligand in preventing graft rejection. Science 377:630-632.
3. Bonetti B, Pohl J, Gao Y, Raine C. 1997a. Cell death during autoimmune demyelinationL: effector but not target cells are eliminated by apoptosis. J Immunol 159:5733-5741.
4. Bonetti M, Raine C. 1997b. Oligodendrocytes display cell death related molecules in situ but do not undergo apoptosis. Ann Neurol 42: 74-84.
5. Brunner T, Mogil R, LaFace D, Yoo N, Mahboubi A, Echeverri F, Martin S, Force W, Lynch D, Ware C 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444.
6. Cserr H, Knopf P. 1992. Cervival lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 13:507-512.
7. Dowling P, Shang G, Raval S, Menonna J, Cookand S, Husar W. 1996. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 184:1513-1518.
8. D'Souza S, Bonetti B, Balasingman V, Cashman N, Barker P, Troutt A, Raineand C, Antel J. 1996. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184:3261-3370.
9. Fiedler P, Schaetzlein CE, Eibel H. 1998. Technical comment. Science 279.
10. Ford AL, Foulcher E, Lemckertand FA, Sedgwick JD. 1996. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184:1737-1745.
11. Gavrieli Y, Sherman Y, Ben-Sasson S. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
12. Giulian D, Baker TJ. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163-2178.
13. Gold R, Schmied M, Tontsch U, Hartung H, Wekerle H, Toyka K, Lassmann H. 1996. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death: a model for T-cell apoptosis in vivo. Brain 119:651-659.
14. Gold R, Hartung H, Lassmann H. 1997. T-cell apoptosis in autoimmune diseases - termination of inflammation in the nervous system and other sites with specialized immune-defense mechanism. Trends Neurosci 20:399-404.
15. Griffith T, Ferguson T. 1997. The role of FasL-induced apoptosis in immune privilege. Immunol Today 18:240-244.
16. Hertz L, Juurlink B, Fosmarkand H, Schousboe A. 1989. Preparation of primary cultures of mouse (rat) astrocytes. In: Shahar A, Vellis J, Vernadakisand A, editors. A dissection and tissue culture manual of the nervous system. New York: Alan R. Liss, Inc. p 105-108.
17. Hickey WF, Hsu BL, Kimura H. 1991. T-Lymphocyte entry into the central nervous system. J Neurosci Res 28:254-260.
18. Hirschberg DL, Schwartz M. 1995. Macrophage recruitment to acutely injured central nervous system is inhibited by a resident factor: a basis for an immune-brain barrier. J Neuroimmunol 61:89-96.
19. Kiener PA, Davis PM, Rankin BM, Klebanoff SJ, Ledbetter JA, Starling GC, Liles WC. 1997. Human monocytic cells contain high levels of intracellular Fas ligand. J Immunol 159:1594-1598.
20. Lassmann H, Schmied M, Vassand K, Hickey WF. 1993. Bone marrow derived elements and resident microglia in brain inflammation. Glia 7:19-24.
21. Li JH, Rosen D, Ronen D, Behrens CK, Krammer PH, Clark WR., Berke G. 1998. The regulation of CD95 ligand expression and function in CTL. J Immunol 161:3943-3949.
22. Martinez-Lorenzo MJ, Alava MA, Anel A, Pineiro A, Naval J. 1996. Release of preformed Fas ligand in its soluble form is the major factor for activation induced death of Jurkat T-cells. Immunology 89:511-517.
23. Medawar PB. 1948. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29:58-69.
24. Merril JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA 89:574-578.
25. Miyawaki T, Vehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taguchi N. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753-3758.
26. Mor G, Gutierrez L, Eliza M, Kahyaoglu F, Arici A. 1998. Fas-Fas ligand system induced apoptosis in human placenta and gestational trophoblastic disease. Am J Reprod Immunol 40:89-95.
27. Nagata S, Golstein P. 1995. The Fas death factor. Science 267:1449-1456.
28. Ohmori K, Hong Y, Fujiwara M, Matsumoto Y. 1992. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis: evidence suggesting that most infiltrating T cells do not proliferate in the target organ. Lab Invest 66:54-62.
29. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197-205.
30. Papoff G, Stassi G, Giordano C, Galluzzo A, Bagnasco M, Ruberti G, Testi R. 1998. Technical comment. Science 279:2015a.
31. Pender M, Nguyen K, McCombe P, Kerr J. 1991. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104:81-87.
32. Rieckmann P, Albrecht M, Kitze B, Weber T. Tumani H, Brooks A, Luer W, Helwig A, Poser S. 1995. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37:82-88.
33. Saas P, Walker P, Hahne M, Quiquerez A, Schnuriger V, Perrin G, French L, Vanmeir E, Detribolet N, Tschopp J, Dietrich P. 1997. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain. J Clin Invest 99:1173-1178.
34. Sabelko KA, Kelly KA, Nahm MH, Cross AH, Russell H. 1997. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol 159:3096-3099.
35. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, Lassmann H. 1993. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Am J Pathol 143:446-452:143: 446-452.
36. Smith D, Sieg S, Kaplan D. 1998. Technical note: aberrant detection of Fas ligand with anti-peptide antibodies. J Immunol 160:4159-4160.
37. Stokes TA, Rymaszewski M, Arscott PL, Wang SH, Bretz JD, Bartron J, Baker JR Jr. 1998. Technical comment. Science 279:2015a.
38. Suda T, Takahashi T, Golstein P, Nagata S. 1993. Molecular cloning and expression of fas Ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-78.
39. Takahashi Y, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 6:1567-1574.
40. Waldner H, Sobel R, Howard E, Kuchroo V. 1997. Fas-and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 159:3100-3103.
41. Wekerle H. 1993. Lymphocyte traffic to the brain In: Pardridg WM, editor. The blood-brain barrier. New York: Raven Press. p 67-85.
42. Zipp F, Martin R, Lichtenfels R, Roth W, Dichgans J, Krammer PH, Weller M. 1997. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. J Immunol 159:2108-2115.